Skip to content

ESLA

Estrella Immunopharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.34
−19.84%
Ask drillr

Leverage

Debt / equity
0.00x
Net debt / equity
0.02x
Debt / assets
0.00x
Debt / EBITDA
0.00x
Net debt / EBITDA
0.01x

Liquidity & coverage

Current ratio
0.20x
Quick ratio
0.20x
Cash ratio
0.02x
Interest coverage
—
EBITDA / interest
—
Working capital
-$7.4M

Cash & dividend

FCF / debt
—
Cash flow / debt
—
Dividend per share
—
Dividend yield
—
Dividend growth 1y
—

Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026